Blood diagnosis for Alzheimer’s disease

IHD develops innovative methods for Alzheimer’s diagnosis under an exclusive license agreement with CNRS (owner of the patents). DiagAlz tests can be performed on very small blood samples, since only few droplets are enough. They used genuine fluorescent probes, which recognize biological markers specific for Alzheimer’s patients.

DiagAlz tests have numerous advantages as compared to other methods: they are easy to use and not painful. They are quick, cost effective and their reliability is close to 100%.